0001415889-22-012604.txt : 20221215 0001415889-22-012604.hdr.sgml : 20221215 20221215191237 ACCESSION NUMBER: 0001415889-22-012604 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221213 FILED AS OF DATE: 20221215 DATE AS OF CHANGE: 20221215 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Torley Helen CENTRAL INDEX KEY: 0001528185 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-32335 FILM NUMBER: 221466113 MAIL ADDRESS: STREET 1: C/O ONYX PHARMACEUTICALS, INC. STREET 2: 249 EAST GRAND AVE. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HALOZYME THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001159036 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 880488686 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11388 SORRENTO VALLEY ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121-1345 BUSINESS PHONE: (858) 794-8889 MAIL ADDRESS: STREET 1: 11388 SORRENTO VALLEY ROAD CITY: SAN DIEGO STATE: CA ZIP: 92121-1345 FORMER COMPANY: FORMER CONFORMED NAME: HALOZYME THERAPEUTICS INC DATE OF NAME CHANGE: 20040312 FORMER COMPANY: FORMER CONFORMED NAME: GLOBAL YACHT SERVICES INC DATE OF NAME CHANGE: 20010912 4 1 form4-12162022_121213.xml X0306 4 2022-12-13 0001159036 HALOZYME THERAPEUTICS, INC. HALO 0001528185 Torley Helen C/O HALOZYME THERAPEUTICS, INC. 11388 SORRENTO VALLEY ROAD SAN DIEGO CA 92121 true true false false PRESIDENT AND CEO Common Stock 2022-12-13 4 M 0 10000 14.66 A 597177 D Common Stock 2022-12-13 4 S 0 9507 58.639 D 587670 D Common Stock 2022-12-13 4 S 0 493 59.12 D 587177 D Common Stock 2022-12-14 4 M 0 10000 14.66 A 597177 D Common Stock 2022-12-14 4 S 0 10000 58.298 D 587177 D Common Stock 2022-12-15 4 M 0 10000 14.66 A 597177 D Common Stock 2022-12-15 4 S 0 9104 57.288 D 588073 D Common Stock 2022-12-15 4 S 0 896 58.197 D 587177 D Option to Purchase Common Stock 14.66 2022-12-13 4 M 0 10000 14.66 D 2024-01-06 Common Stock 10000 110000 D Option to Purchase Common Stock 14.66 2022-12-14 4 M 0 10000 14.66 D 2024-01-06 Common Stock 10000 100000 D Option to Purchase Common Stock 14.66 2022-12-15 4 M 0 10000 14.66 D 2024-01-06 Common Stock 10000 90000 D The options exercised and sales reported on this Form 4 were made pursuant to a written trading plan adopted by the Reporting Person on September 7, 2022 in accordance with Rule 10b5-1. Represents a weighted average sales price per share. The shares were sold at prices ranging from $58.11 to $59.01. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Represents a weighted average sales price per share. The shares were sold at prices ranging from $58.11 to $58.49. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Represents a weighted average sales price per share. The shares were sold at prices ranging from $57.00 to $57.98. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Represents a weighted average sales price per share. The shares were sold at prices ranging from $58.02 to $58.22. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Grant to Reporting Person of options, exercisable over a 4-year period measured from the date of grant, 25% after 12 months, then 1/48th of the Option Shares per month thereafter. The date of grant was January 6, 2014. /s/ James R. Oehler, Attorney-in-Fact 2022-12-15